Status:
COMPLETED
Shared Decision Making Between Patients and GPs in the Treatment of Type 2 Diabetes in Primary Care.
Lead Sponsor:
UMC Utrecht
Conditions:
Type 2 Diabetes Mellitus
Eligibility:
All Genders
60-80 years
Phase:
NA
Brief Summary
Background: Less than 20% of type 2 diabetes mellitus (T2DM) patients in different healthcare settings achieve all treatment goals to prevent cardiometabolic disease. A more personalised approach with...
Detailed Description
See brief summary
Eligibility Criteria
Inclusion
- Two more or less comparable categories of patients are eligible: 1. if diagnosed with T2DM in 2002-2004 by screening, aged between 50-70 years at that time and having participated in the ADDITION-study that ended in 2009; 2. treated for their T2DM in a practice that participated in the ADDITION study, between 60 and 80 years in 2012-2014 and with a T2DM duration between 8 to 15 years.
Exclusion
- Patients will be excluded if they have a history of alcoholism, drug abuse, psychosis, personality disorder or another emotional, psychological or intellectual problem that is likely to invalidate informed consent, or limit the ability of the individual to comply with the protocol requirements and patients with a limited life expectancy.
Key Trial Info
Start Date :
March 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2016
Estimated Enrollment :
153 Patients enrolled
Trial Details
Trial ID
NCT02285881
Start Date
March 1 2012
End Date
February 1 2016
Last Update
May 13 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Julius Centre for Health Sciences and Primary Care
Utrecht, Netherlands, 3584CG